Sith Sathornsumetee
Overview
Explore the profile of Sith Sathornsumetee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
3940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dana P, Bunthot S, Suktham K, Surassmo S, Yata T, Namdee K, et al.
Colloids Surf B Biointerfaces
. 2020 Aug;
196:111270.
PMID: 32777659
Cisplatin (Cis) is a widely used chemotherapeutic drug for cancer treatment. However, toxicities and drug resistance limit the use of cisplatin. This study was aimed to improve cisplatin delivery using...
12.
Bovonsunthonchai S, Witthiwej T, Ngamsombat C, Sathornsumetee S, Vachalathiti R, Muangpaisan W, et al.
Nagoya J Med Sci
. 2018 Mar;
80(1):53-60.
PMID: 29581614
The aim of the study was to investigate the effect of the spinal tap test on sit-to-stand (STS), walking, and turning and to determine the relationship among the outcome measures...
13.
Srivanitchapoom P, Pitakpatapee Y, Sitthinamsuwan P, Sathornsumetee S
Clin Neurol Neurosurg
. 2018 Feb;
167:62-64.
PMID: 29454181
Cryptococcal meningoencephalitis is one of the most common central nervous system infections affecting immunocompromised patients. However, brainstem involvement is extremely rare and may represent a diagnostic challenge to clinicians. We...
14.
Sanvoranart T, Supokawej A, Kheolamai P, U-Pratya Y, Poungvarin N, Sathornsumetee S, et al.
Tumour Biol
. 2016 Sep;
37(11):14949-14960.
PMID: 27651158
Glioblastoma (GBM) is an aggressive malignant brain tumor that still lacks effective therapy. Glioblastoma stem cells (GBM-SCs) were identified to contribute to aggressive phenotypes and poor clinical outcomes for GBM....
15.
Sathornsumetee S, Cheunsuchon P, Sangruchi T
World Neurosurg
. 2016 Mar;
91:518-523.e1.
PMID: 26960282
Objective: To investigate the relationship between 3 hypoxic markers, carbonic anhydrase-9 (CA-9), hypoxia-inducible factor (HIF)-1α, and HIF-2α and the traditional genetic markers, deletions of chromosomes 1p and 19q and Isocitrate...
16.
Srivanitchapoom P, Sathornsumetee S
Neurology
. 2015 Sep;
85(10):e79-80.
PMID: 26346832
No abstract available.
17.
Chawalparit O, Sangruchi T, Witthiwej T, Sathornsumetee S, Tritrakarn S, Piyapittayanan S, et al.
J Med Assoc Thai
. 2013 Dec;
96(10):1365-73.
PMID: 24350420
Objective: To evaluate the usefulness of advanced MRI techniques in differentiating high-grade (HGG) from low-grade gliomas (LGG). Material And Method: Sixty-four patients with suspected gliomas were prospectively evaluated by conventional...
18.
Direksunthorn T, Chawalparit O, Sangruchi T, Witthiwej T, Tritrakarn S, Piyapittayanan S, et al.
J Med Assoc Thai
. 2013 Oct;
96(9):1183-90.
PMID: 24163995
Background: To determine the usefulness of the perfusion MRI technique at Siriraj Hospital for differentiating between high- and low-grade gliomas by using pathological results as the gold standard. Material And...
19.
Piyapittayanan S, Chawalparit O, Tritakarn S, Witthiwej T, Sangruchi T, Nunta-Aree S, et al.
J Med Assoc Thai
. 2013 Aug;
96(6):716-21.
PMID: 23951830
Objective: To determine the usefulness of diffusion tensor imaging (DTI) in differentiating high-grade glioma (HGG) from low-grade glioma (LGG). Material And Method: Patients with cerebral gliomas underwent conventional MRI and...
20.
Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2013 May;
14(4):319-23.
PMID: 23638638
No abstract available.